Ubs Asset Management Americas Inc Collegium Pharmaceutical, Inc Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 59,326 shares of COLL stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,326

Previous 69,310 14.4%

Holding current value

$1.78 Million

Previous $2.23 Million 2.73%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$31.4 - $39.07 $313,497 - $390,074	-9,984 Reduced 14.4%	59,326 $2.29 Million
Q2 2024 Aug 13, 2024	BUY	$31.36 - $39.99 $1.21 Million - $1.54 Million	38,581 Added 125.55%	69,310 $2.23 Million
Q1 2023 May 15, 2023	SELL	$23.0 - $29.88 $136,321 - $177,098	-5,927 Reduced 16.17%	30,729 $737,000
Q4 2022 Feb 14, 2023	BUY	$16.14 - $23.55 $111,995 - $163,413	6,939 Added 23.35%	36,656 $850,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $24,086 - $31,315	1,558 Added 5.53%	29,717 $476,000
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $7,906 - $11,609	-556 Reduced 1.94%	28,159 $498,000
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $6,326 - $7,356	291 Added 1.02%	28,715 $678,000
Q1 2021 May 14, 2021	SELL	$19.25 - $26.1 $38,692 - $52,461	-2,010 Reduced 6.6%	28,424 $673,000
Q4 2020 Mar 01, 2021	BUY	$17.83 - $22.29 $50,316 - $62,902	2,822 Added 10.22%	30,434 $609,000
Q3 2020 Nov 13, 2020	SELL	$15.78 - $20.82 $7,258 - $9,577	-460 Reduced 1.64%	27,612 $574,000
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $3.48 Million - $5.28 Million	-224,618 Reduced 88.89%	28,072 $491,000
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $543,640 - $996,087	-39,139 Reduced 13.41%	252,690 $4.13 Million
Q4 2019 Feb 14, 2020	SELL	$10.7 - $22.24 $15,632 - $32,492	-1,461 Reduced 0.5%	291,829 $6.01 Million
Q3 2019 Nov 14, 2019	SELL	$10.16 - $13.28 $44,927 - $58,724	-4,422 Reduced 1.49%	293,290 $3.37 Million
Q2 2019 Aug 15, 2019	SELL	$10.62 - $16.59 $63,040 - $98,478	-5,936 Reduced 1.95%	297,712 $0
Q1 2019 May 14, 2019	SELL	$13.58 - $18.72 $22,176 - $30,569	-1,633 Reduced 0.53%	303,648 $0
Q4 2018 Feb 13, 2019	BUY	$14.78 - $19.68 $4.33 Million - $5.76 Million	292,781 Added 2342.25%	305,281 $5.24 Million
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $272,375 - $353,625	12,500 New	12,500 $0

Others Institutions Holding COLL

# of Institutions

255

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Collegium Pharmaceutical, Inc Transaction History